BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9717537)

  • 1. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
    Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
    Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen-progestin and estrogen on mammographic density.
    Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
    J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of hormone replacement therapy on the mammographic density of the female breast].
    Egyed Z; Péntek Z; Magyar Z
    Magy Onkol; 2005; 49(4):319-21, 323-5. PubMed ID: 16518476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
    J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast density in women with premature ovarian failure using hormone therapy.
    Benetti-Pinto CL; Soares PM; Magna LA; Petta CA; Dos Santos CC
    Gynecol Endocrinol; 2008 Jan; 24(1):40-3. PubMed ID: 18224543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
    Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
    Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of low dose hormone therapy on mammographic breast density.
    Christodoulakos GE; Lambrinoudaki IV; Vourtsi AD; Vlachou S; Creatsa M; Panoulis KP; Botsis D
    Maturitas; 2006 Apr; 54(1):78-85. PubMed ID: 16198519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.
    Panoulis C; Lambrinoudaki I; Vourtsi A; Augoulea A; Kaparos G; Aravantinos L; Christodoulakos G; Creatsas G
    Climacteric; 2009 Jun; 12(3):240-7. PubMed ID: 19387881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic changes related to different types of hormonal therapies.
    Pongsatha S; Muttarak M; Chaovisitseree S; Luewan S; Panpanit A
    J Med Assoc Thai; 2006 Feb; 89(2):123-9. PubMed ID: 16578996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring the breast changes of Chinese postmenopausal women under long-term hormone replacement therapy by mammary ultrasonography].
    Huang MT; Jiang YX; Lin SQ; Zhang Y; Zhou YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):24-9. PubMed ID: 15052769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and breast density changes.
    Harvey J; Scheurer C; Kawakami FT; Quebe-Fehling E; de Palacios PI; Ragavan VV
    Climacteric; 2005 Jun; 8(2):185-92. PubMed ID: 16096175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
    Eilertsen AL; Karssemeijer N; Skaane P; Qvigstad E; Sandset PM
    BJOG; 2008 May; 115(6):773-9. PubMed ID: 18355366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
    Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
    Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.
    Stomper PC; Van Voorhis BJ; Ravnikar VA; Meyer JE
    Radiology; 1990 Feb; 174(2):487-90. PubMed ID: 2136958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does a short cessation of HRT decrease mammographic density?
    Weaver K; Kataoka M; Murray J; Muir B; Anderson E; Warren R; Warsi I; Highnam R; Glasier A
    Maturitas; 2008 Apr; 59(4):315-22. PubMed ID: 18448281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.
    Lasco A; Gaudio A; Morini E; Morabito N; Nicita-Mauro C; Catalano A; Denuzzo G; Sansotta C; Xourafa A; Macrì I; Frisina N
    Menopause; 2006; 13(5):787-92. PubMed ID: 16912660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.